Journal
SCIENCE TRANSLATIONAL MEDICINE
Volume 10, Issue 443, Pages -Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/scitranslmed.aan4116
Keywords
-
Categories
Funding
- UMass Amherst
- U.S. Department of Agriculture's National Institute of Food and Agriculture (USDA NIFA) [2016-67017-24423]
- NIH/National Cancer Institute [R03CA218520]
- USDA NIFA [2016-6701724416, 2014-67021-21598, 2016-67021-25147]
- National Natural Science Foundation of China [21676212]
- NIFA [2014-67021-21598, 688149, 810853, 2016-67017-24423] Funding Source: Federal RePORTER
Ask authors/readers for more resources
Triclosan (TCS) is a high-volume chemical used as an antimicrobial ingredient in more than 2000 consumer products, such as toothpaste, cosmetics, kitchenware, and toys. We report that brief exposure to TCS, at relatively low doses, causes low-grade colonic inflammation, increases colitis, and exacerbates colitis-associated colon cancer in mice. Exposure to TCS alters gut microbiota in mice, and its proinflammatory effect is attenuated in germ-free mice. In addition, TCS treatment increases activation of Toll-like receptor 4 (TLR4) signaling in vivo and fails to promote colitis in Tlr4(-/-) mice. Together, our results demonstrate that this widely used antimicrobial ingredient could have adverse effects on colonic inflammation and associated colon tumorigenesis through modulation of the gut microbiota and TLR4 signaling. Together, these results highlight the need to reassess the effects of TCS on human health and potentially update policies regulating the use of this widely used antimicrobial.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available